TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PRME

Prime Medicine, Inc.

Healthcare · Biotechnology

3.20$ +2.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Prime Medicine, Inc. (PRME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 343 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PRME
Line item 2019 2020 2021 2022 2023 2024 2025
8.7 55 302 360 194 298 343
8.7 53 271 297 143 212 181
8.6 37 185 188 42 182 63
8.6 53 270 294 122 190 178
0.6 16 19
7.3 21 62 44 61 144 222
7.3 19 58 27 56 38 37
18 7.3 12 9.3 3.6 8.1
0.3 1.4 4.3 20 11 8.9
1.4 33 240 316 133 153 121
-2.6 -6.0 -171 -293 -491 -687 -888
96 96 96 97 91 119 149

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?